Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)

Clinical trial NCT05224960 · RECRUITING

Trial details

NCT number: NCT05224960
Sponsor: Beijing 302 Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Decompensated Cirrhosis

Start date: 2024-06-27
Primary completion: 2025-06-27
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.